Skip to content

Vax Facts Human Papillomavirus (HPV): Study of a Computer-based Tailoring System and Mothers' Intentions to Vaccinate Their Daughters Against HPV

Vax Facts HPV: Study of a Computer-based Tailoring System and Mothers' Intentions to Vaccinate Their Daughters Against HPV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01143142
Enrollment
70
Registered
2010-06-14
Start date
2010-06-30
Completion date
2011-10-31
Last updated
2014-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papillomavirus, Prevention

Keywords

Human papillomavirus, HPV, Prevention, Tailoring, Persuasive communication, Adolescent

Brief summary

The goal of this study is to determine whether a two-page print brochure that delivers individually tailored educational messages about the Human papillomavirus (HPV) vaccine increases HPV vaccine-hesitant mothers' intentions to have their adolescent daughters vaccinated against HPV.

Detailed description

This will be a randomized controlled intervention trial for HPV vaccine-hesitant mothers of adolescent (ages 11-15 years old) girls. Mothers will complete a three-item measure that assesses their baseline intentions for having their adolescent daughter vaccinated against HPV. Mothers will then fill out a short, computer-based survey that assesses demographic factors, prior experience with HPV-associated illnesses and views about a variety of potential barriers to HPV vaccination. Following the survey, the intervention group (40 mothers) will receive a two-page print brochure that uses their survey data to generate the brochure such that it addresses each mother's top three concerns about the HPV vaccine. The control group (40 mothers) will receive a generic, two-page brochure that is similar in appearance to the intervention, but contains only untailored, generic information about the vaccine. HPV vaccination intention will be assessed a second time after reading the brochure, using the same three-item measure as before the survey. The vaccine administration records of the adolescent daughters of these mothers will be accessed three months after mothers' participation in the study to assess whether any HPV vaccine doses were provided.

Interventions

BEHAVIORALComputer-based tailoring system

Both the intervention and control groups will use a computer-based tailoring system to respond to survey questions. The computer-based tailoring system will produce messages for a two-page educational brochure based on participants' responses to survey questions. Only the intervention group will receive this brochure.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Mother is greater than or equal to 18 years of age * Mother has a daughter who is between the ages of 11-15 years * Daughter has not received any doses of the HPV vaccine * When asked to describe how she feels about getting her daughter vaccinated against HPV in the next six months, mother responds I don't want her to get vaccinated or I'm unsure if I want her vaccinated.

Exclusion criteria

* Cannot read/speak English

Design outcomes

Primary

MeasureTime frameDescription
Mother's Intention to Vaccinate Daughter Against HPVDate of intervention (one day)Mother will rate her intention to have her daughter vaccinated against HPV using a Likert scale before and after the intervention. The scale ranges from 0-11 with higher numbers representing more positive intentions to vaccinate against HPV, and 5 being neutral intentions (i.e. neither positive nor negative). In this assessment we use this 11-point scale to assess vaccination before and after viewing the educational materials. The difference pre and post intervention in vaccination intention is calculated (min 0, max 11) and the mean of these differences are calculated for the control and intervention groups.

Secondary

MeasureTime frameDescription
Vaccination of DaughterLess than or equal to three months from the date of the interventionWith mother's consent, daughter's University of Michigan vaccination record will be accessed to determine whether daughter has received any doses of the HPV vaccine. If the University of Michigan vaccination record does not document a visit three months after the intervention, with mother's consent, research staff will call mother at home to determine whether daughter has received any doses of the HPV vaccine.

Countries

United States

Participant flow

Participants by arm

ArmCount
Tailoring
Individuals assigned to the experimental group will receive a two-page brochure tailored based on their responses to the survey. Computer-based tailoring system: Both the intervention and control groups will use a computer-based tailoring system to respond to survey questions. The computer-based tailoring system will produce messages for a two-page educational brochure based on participants' responses to survey questions. Only the intervention group will receive this brochure.
36
Untailored Information
Individuals assigned to the control group will receive the CDC vaccine information sheet that is standardly provided. Computer-based tailoring system: Both the intervention and control groups will use a computer-based tailoring system to respond to survey questions. The computer-based tailoring system will produce messages for a two-page educational brochure based on participants' responses to survey questions. Only the intervention group will receive this brochure.
34
Total70

Baseline characteristics

CharacteristicTailoringTotalUntailored Information
Age, Continuous40 years40 years40 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
9 Participants18 Participants9 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants4 Participants2 Participants
Race (NIH/OMB)
White
25 Participants47 Participants22 Participants
Region of Enrollment
United States
36 participants70 participants34 participants
Sex: Female, Male
Female
36 Participants70 Participants34 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 360 / 34
serious
Total, serious adverse events
0 / 360 / 34

Outcome results

Primary

Mother's Intention to Vaccinate Daughter Against HPV

Mother will rate her intention to have her daughter vaccinated against HPV using a Likert scale before and after the intervention. The scale ranges from 0-11 with higher numbers representing more positive intentions to vaccinate against HPV, and 5 being neutral intentions (i.e. neither positive nor negative). In this assessment we use this 11-point scale to assess vaccination before and after viewing the educational materials. The difference pre and post intervention in vaccination intention is calculated (min 0, max 11) and the mean of these differences are calculated for the control and intervention groups.

Time frame: Date of intervention (one day)

ArmMeasureValue (MEAN)
TailoringMother's Intention to Vaccinate Daughter Against HPV1.53 units on a scale
Untailored InformationMother's Intention to Vaccinate Daughter Against HPV1.29 units on a scale
Secondary

Vaccination of Daughter

With mother's consent, daughter's University of Michigan vaccination record will be accessed to determine whether daughter has received any doses of the HPV vaccine. If the University of Michigan vaccination record does not document a visit three months after the intervention, with mother's consent, research staff will call mother at home to determine whether daughter has received any doses of the HPV vaccine.

Time frame: Less than or equal to three months from the date of the intervention

ArmMeasureValue (NUMBER)
TailoringVaccination of Daughter1 participants
Untailored InformationVaccination of Daughter2 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026